Print ISSN:-2394-2789

Online ISSN:-2394-2797

CODEN : IJPCN9

Article History

Received : 10-12-2023

Accepted : 01-01-2024



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 387

PDF Downloaded: 239


Nanostructured dendrimer improves the solubility of carvedilol, furosemide and nimodipine


Full Text PDF Share on Facebook Share on Twitter


Original Article

Author Details : Vidhi Patel, Pravinkumar M. Patel , Jigar V. Patel*

Volume : 11, Issue : 1, Year : 2024

Article Page : 55-61

https://doi.org/10.18231/j.ijpca.2024.008



Suggest article by email

Get Permission

Abstract

Essential hypertension has been treated for over 30 years using both diuretics and beta-blockers. When it comes to treating heart failure, there are three different generations of beta-blockers that are now in use. Carvedilol is a blocker from the third generation. Nimodipine is a common L-type calcium channel blocker. The hypertension medication furosemide is a loop diuretic. This class of medications' low solubility in water has emerged as a serious obstacle in the pharmaceutical industry's pursuit of better treatments. A novel class of polymers called dendrimers has recently gained a lot of interest due to its impressive solubility-enhancing characteristics. Results from hemolysis studies and cytotoxicity tests using the novel nanostructure dendrimer shown here demonstrate superior performance of synthetic dendritic macromolecules compared to commercially available PAMAM dendrimer. Dendrimers are used to enhance the solubility of nimodipine, furosemide, and carvedilol up to 38.08µg/ml, 70.999µg/ml and 147.065µg/ml respectively. The enhancement of dendrimer-mediated solubility is primarily determined by factors such as dendrimer concentration and generation size. Drugs containing dendrimers may be studied using Fourier-transform infrared spectroscopy. Based on the results of this investigation, nanostructured dendrimer technology may help with hydrophobic medication dispersion.


Keywords: Carvedilol, Dendrimer, Furosemide, Nanostructure, Nimodipine, Solubility



How to cite : Patel V, Patel P M, Patel J V, Nanostructured dendrimer improves the solubility of carvedilol, furosemide and nimodipine. Int J Pharm Chem Anal 2024;11(1):55-61


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.